Zalika Pharmaceuticals Private Limited

Zalika Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U74995PN2018PTC176402 Incorporated 03 May 2018 ROC Pune HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
Last financials
Mar 2025
Balance sheet date
Last AGM
30 Sep 2025
Annual general meeting
Company status
Active
MCA master data

About Zalika Pharmaceuticals Private Limited

Data last updated:

Zalika Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 May 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74995PN2018PTC176402. Its GSTIN is 27AABCZ2098P1ZJ (Maharashtra).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ameya Anant Budukh and Sameer Sidhram Kolhe.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 87 Vishal Industrial Estate Opp Ceat Tyres, Village Road Nahur Bhandup West Mumbai, Maharashtra, India – 400078.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U74995PN2018PTC176402
Registration Number 176402
Incorporation Date 03 May 2018
ROC Pune
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Zalika Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.

  • Email
  • Registered Address
    87 Vishal Industrial Estate Opp Ceat Tyres, Village Road Nahur Bhandup West Mumbai, Maharashtra, India – 400078
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Zalika Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Zalika Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Zalika Pharmaceuticals Private Limited

FY 2025 filings available

Financial Statement Summary

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Zalika Pharmaceuticals Private Limited, buy the company report.

Board of directors of Zalika Pharmaceuticals Private Limited

Zalika Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ameya Anant BudukhDirector03 May 20188 Years 6 MonthsCurrent
Sameer Sidhram KolheDirector03 May 20188 Years 6 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Zalika Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Zalika Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AABCZ2098P1ZJMaharashtraActive13 Oct 2018

To see the full GST registrations and return filing status of Zalika Pharmaceuticals Private Limited, buy the company report.

Recent activity

Zalika Pharmaceuticals Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Daniela Lifschitz Tabak ceased to be Director on 23 Jul 2019.

AGM
Zalika Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Zalika Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Ceased
Daniela Lifschitz Tabak ceased to be Director.
Ceased
David Zylbergeld Neto ceased to be Director.
Appointed
Ameya Anant Budukh was appointed as Director.
Appointed
Sameer Sidhram Kolhe was appointed as Director.
Incorporation
03 May 2018
Zalika Pharmaceuticals Private Limited was registered on 03 May 2018 with Roc Pune & aged 8 years 6 months as per MCA records.

Frequently asked questions

Zalika Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 May 2018 (8+ years old) and is registered under CIN U74995PN2018PTC176402.

Zalika Pharmaceuticals has 2 current directors:

The latest financial statements of Zalika Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Zalika Pharmaceuticals is 27AABCZ2098P1ZJ, registered in Maharashtra.

The CIN (Corporate Identification Number) of Zalika Pharmaceuticals is U74995PN2018PTC176402. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Zalika Pharmaceuticals was incorporated on 03 May 2018, making it 8+ years old. It is registered with the Registrar of Companies, Pune.

Daniela Lifschitz Tabak ceased to be Director on 23 Jul 2019. David Zylbergeld Neto ceased to be Director on 23 Jul 2019. Ameya Anant Budukh was appointed as Director on 03 May 2018. Zalika Pharmaceuticals has 4 board changes on record in total.

The registered office of Zalika Pharmaceuticals is at 87 Vishal Industrial Estate Opp Ceat Tyres, Village Road Nahur Bhandup West Mumbai, Maharashtra, India – 400078.

Zalika Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

The compliance status of Zalika Pharmaceuticals is compliant as of 06 August 2026. The company is actively filing with the Registrar of Companies.